Terry Smith has ruled out ever investing in unlisted companies in Fundsmith Equity, his flagship open-ended fund.
Star fund manager Neil Woodford faces more trouble, with one of his largest holdings seeing its share price fall by more than 60% on 7 August.
In a report released by US short-seller Muddy Waters, the London-listed Burford Capital was accused of inflating its earnings and having questionable financial reporting standards.
In early March of this year, when Money Observer first highlighted the worrying issues that would ultimately lead to disaster for investors in LF Woodford Equity Income fund, we listed several reasons for concern, beyond the fund’s (WEIF’s) very poor performance.
Neil Woodford’s Woodford Equity Income fund will remain suspended until early December, according to the latest update from the fund’s management service, Link.
Neil Woodford has sold over half of his stake in Woodford Patient Capital Trust (WPCT), as speculation grows that he may be dropped as manager.
The board of the trust has announced that it has been in talks with “select management groups” recently to discuss future management of the trust.
The bottom-fishers smell an opportunity. Woodford Patient Capital (WPCT) was the most-bought investment trust on interactive investor’s web platform during June, as bargain-hunters sought to cash in on its plummeting rating. But will the opportunists make a killing – and should you join them? Or will Patient Capital’s new shareholders rue the day they ignored that old stockmarket adage about never trying to catch a falling knife?
Almost a month after his Woodford Equity Income fund was suspended, Neil Woodford has released a video that attempts to answer major questions about the future of the fund.
Asked when the fund will resume trading, Woodford gave no clear indication, noting that there was “no prescribed limit” for how long it can remain suspended.